These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2832184)

  • 21. G-protein coupling and signalling of Y1-like neuropeptide Y receptors in SK-N-MC cells.
    Feth F; Rascher W; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):1-7. PubMed ID: 1663584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro.
    Michel MC; Schlicker E; Fink K; Boublik JH; Göthert M; Willette RN; Daly RN; Hieble JP; Rivier JE; Motulsky HJ
    Am J Physiol; 1990 Jul; 259(1 Pt 1):E131-9. PubMed ID: 2164786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS; Halaris AE
    Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.
    Voisin T; Rouyer-Fessard C; Laburthe M
    Am J Physiol; 1990 May; 258(5 Pt 1):G753-9. PubMed ID: 2159240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cyclic analog of neuropeptide Y specific for the Y2 receptor.
    Beck-Sickinger AG; Grouzmann E; Hoffmann E; Gaida W; van Meir EG; Waeber B; Jung G
    Eur J Biochem; 1992 Jun; 206(3):957-64. PubMed ID: 1318842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding sites for 125I-neuropeptide Y (NPY) on membranes from bovine adrenal medulla.
    Cherdchu C; Deupree JD; Hexum TD
    Eur J Pharmacol; 1989 Dec; 173(2-3):115-9. PubMed ID: 2625132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and characterization of neuropeptide Y binding sites in porcine and human colon.
    Walsh DA; Wharton J; Blake DR; Polak JM
    Br J Pharmacol; 1993 Feb; 108(2):304-11. PubMed ID: 8448582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J; Modin A; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of the role of the amphipathic alpha-helix in the interaction of neuropeptide Y and active cyclic analogues with cell membrane receptors and dimyristoylphosphatidylcholine.
    McLean LR; Buck SH; Krstenansky JL
    Biochemistry; 1990 Feb; 29(8):2016-22. PubMed ID: 2158344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilization of the neuropeptide Y receptor from rat brain membranes.
    Mannon PJ; Mervin SJ; Taylor IL
    J Neurochem; 1991 May; 56(5):1804-9. PubMed ID: 1849554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J; Svenberg T; Lundberg JM
    Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
    Ohtomo Y; Ono S; Zettergren E; Sahlgren B
    Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Hamberger B
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.